HSPA5 and breast cancer: Moreover, the nanocarrier‐conjugated scFvs, such as quantum dot conjugated GRP78 scFv, exhibit biological antitumor activity in breast cancer models, suggesting the application as a therapeutic antibody for cancer treatment.387